10x Genomics (TXG) Net Income Growth (3y) (2021 - 2026)

10x Genomics (TXG) Net Income Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Veeva Systems 32.11 Bn 24.80 Bn 662.02 Mn 25.65%
2 BrightSpring Health Services 14.63 Bn 13.73 Bn 482.22 Mn 74.75%
3 Healthequity 8.30 Bn 8.03 Bn 256.31 Mn 156.91%
4 Hinge Health 5.97 Bn 5.66 Bn 154.23 Mn -
5 10x Genomics 5.94 Bn 5.40 Bn 106.18 Mn 35.73%
6 MiniMed 4.52 Bn 4.22 Bn 480.00 Mn -
7 Waystar Holding 4.47 Bn 4.40 Bn 216.84 Mn -
8 Doximity 3.96 Bn 3.22 Bn 125.97 Mn -14.58%
9 Privia Health 3.14 Bn 2.72 Bn - -16.74%
10 Omnicell 1.87 Bn 1.63 Bn 140.36 Mn 40.24%

Historic Data

Download Data
DateValue
Mar 31, 2026 35.73%
Dec 31, 2025 1.90%
Sep 30, 2025 13.14%
Jun 30, 2025 36.37%
Mar 31, 2025 6.78%
Dec 31, 2024 -38.51%
Sep 30, 2024 -27.69%
Jun 30, 2024 -50.80%
Mar 31, 2024 -73.14%
Dec 31, 2023 50.98%
Sep 30, 2023 -12.19%
Jun 30, 2023 -15.83%
Mar 31, 2023 -33.89%
Dec 31, 2022 -34.07%
Sep 30, 2022 -63.42%
Jun 30, 2022 -80.78%
Mar 31, 2022 -126.79%
Dec 31, 2021 37.49%
Sep 30, 2021 -3.82%